(VIANEWS) – The NYSE ended the session with Teva Pharmaceutical (TEVA) rising 5.53% to $10.68 on Friday while NYSE dropped 0.28% to $15,224.21.


Today’s last reported volume for Teva Pharmaceutical is 18356100, 42.27% above its average volume of 12901900.

Teva Pharmaceutical’s last close was $10.12, 3.62% under its 52-week high of $10.50.

Teva Pharmaceutical’s Sales

Teva Pharmaceutical’s sales growth is a negative 3.7% for the current quarter and a decline by 1.6% for the next.

Teva Pharmaceutical’s Revenue

Year-on-year quarterly revenue growth declined by 7.9%, now sitting on 15.88B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Teva Pharmaceutical’s stock is considered to be oversold (<=20).

Teva Pharmaceutical’s Stock Yearly Top and Bottom Value

Teva Pharmaceutical’s stock is valued at $10.68 at 19:13 EST, higher than its 52-week high of $10.50.

Teva Pharmaceutical’s Moving Average

Teva Pharmaceutical’s worth is way higher than its 50-day moving average of $8.57 and way above its 200-day moving average of $8.75.

More news about Teva Pharmaceutical (TEVA).


Please enter your comment!
Please enter your name here